Back
Sarepta Therapeutics Vs. AbbVie Industry Stock Comparison
Sell
37
SRPT
Sarepta Therapeutics
Last Price:
117.81
Seasonality Move:
12.59%
Sell
37
ABBV
AbbVie
Last Price:
164.29
Seasonality Move:
4.33%
Sell
37
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $117.21. The Score for SRPT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
AbbVie (ABBV)
is a Sell
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $162.54. The Score for ABBV is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- ABBV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $117.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
ABBV Stock Price Chart
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.26 | Sell |
Relative Strength Index (14 RSI): | 30.48 | Sell |
Chaikin Money Flow: | -370070 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (122.11 - 128.27) | Sell |
Bollinger Bands (100): | (96.69 - 130.81) | Buy |
ABBV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.62 | Sell |
Relative Strength Index (14 RSI): | 28.83 | Sell |
Chaikin Money Flow: | -2115749 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (168.32 - 181.28) | Sell |
Bollinger Bands (100): | (152.98 - 178.12) | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 123.55 | Sell |
20-day SMA: | 125.76 | Sell |
50-day SMA: | 126.88 | Sell |
200-day SMA: | 111.22 | Buy |
8-day EMA: | 122.39 | Sell |
20-day EMA: | 124.54 | Sell |
50-day EMA: | 123.32 | Sell |
200-day EMA: | 115.63 | Buy |
ABBV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 166.62 | Sell |
20-day SMA: | 173.59 | Sell |
50-day SMA: | 175.72 | Sell |
200-day SMA: | 155.6 | Buy |
8-day EMA: | 166.45 | Sell |
20-day EMA: | 171.25 | Sell |
50-day EMA: | 172.05 | Sell |
200-day EMA: | 160.29 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.93 per share, an increase next quarter of $3.01 per share, an increase this year of $5.19 per share, and an increase next year of $7.38 per share.
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.18 per share, an increase this year of $0.06 per share, and an increase next year of $0.95 per share.
Sarepta Therapeutics Technical Analysis
Apr 3 | Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
AbbVie Technical Analysis
Apr 3 | Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |